Skip to main content
Ogbogwu

Supply report · October 2026 register copy

Eye & Ear Drops in Nigeria: the registration data

Across the 3 eye and ear drop molecules Ogbogwu tracks, our October 2026 copy of the NAFDAC Greenbook lists 77 active registrations held by 49 companies — plus 89 registrations recorded as no longer active. Every figure on this page is quoted from that dated copy; the register can change after our copy is taken.

Active registrations
77
Companies
49
New in the last 12 months
7
Renewals due within a year
9

Who holds the registrations

The ten companies with the most active eye and ear drop registrations in our copy. The registrant is the NAFDAC applicant of record — for imported lines this is often the Nigerian distributor, not the factory.

  1. 1.Maydon Pharmaceuticals— 5 active
  2. 2.Pharmacy Plus— 5 active
  3. 3.Fidson Healthcare— 3 active
  4. 4.Krishat Pharma Industries— 3 active
  5. 5.Mankind Life-Sciences— 3 active
  6. 6.Aphantee Pharma Nigeria— 2 active
  7. 7.BUCHCOLL PHARMACEUTICALS— 2 active
  8. 8.Chevnor Pharmaceutical— 2 active
  9. 9.City of Glory— 2 active
  10. 10.Derm Pharmaceuticals— 2 active

Where the products are made

Maker country as the register records it, across the 77 active registrations.

  • India— 58 (75%)
  • Nigeria— 9 (12%)
  • China— 3 (4%)
  • Bangladesh— 2 (3%)
  • Egypt— 1 (1%)
  • Pakistan— 1 (1%)
  • Saudi Arabia— 1 (1%)
  • UK— 1 (1%)

Dosage forms

  • Tablet— 44 active
  • Eye drops— 17 active
  • Capsule— 4 active
  • Ear/eye drops— 4 active
  • Solution/Drops— 3 active
  • Ear drops— 1 active
  • Eye ointment— 1 active
  • Film coated tablet— 1 active

Newest registrations

The latest eye and ear drop approvals in our copy — 7 products were registered in the twelve months to October 2026.

  • AMAKIN OFLOXACIN TABLETS — B4-3186, approved 2026-01-27
  • Ofloxacin Tablets 200 mg — A4-101191, approved 2025-12-17
  • Bgvid 400 Tablet — C4-0270, approved 2025-11-26
  • Ofloxacin Tablets 200 mg — A4-101642, approved 2025-10-29
  • Ofloxacin Tablets 400 mg — A4-101641, approved 2025-10-29

All new registrations, updated monthly →

9 active registrations carry expiry dates within the next twelve months. A registration expiry means a renewal is due, not that the product disappears — holders routinely renew — but a lapsed number on a pack is worth checking before a large order. See which ones, by month →

The molecules behind these numbers

“Eye & Ear Drops” on this page means these molecules — the register itself has no therapeutic grouping, so a category page must say exactly what it counted.

The most-supplied presentations

Manufacturing or exporting eye and ear drop medicines?

This is the market you'd be entering. See what NAFDAC registration and import into Nigeria require, and talk to us about distribution.

Supply the Nigerian market

Other supply reports

This page quotes the public NAFDAC Greenbook as of our dated copy, across the molecules Ogbogwu tracks in this category. It is a record of registrations, not market-share or sales data, and not an endorsement of any product. Registration status can change; for decisions that matter, confirm on the official Greenbook.